United States-Taiwan Tax Agreement Authorization Act United States-Taiwan Expedited Double-Tax Relief Act

Interstate Transport Act of 2025

TORNADO Act Tornado Observations Research and Notification Assessment for Development of Operations Act

Ending Improper Payments to Deceased People Act

Charitable Act

Rural Hospital Support ActThis bill modifies and extends certain payment adjustments for rural hospitals under Medicare's inpatient prospective payment system.Specifically, the bill indexes payment adjustments for sole community hospitals and Medicare-dependent hospitals to FY2016 operating costs, if it results in higher payments for such hospitals. The bill also makes payment adjustments for Medicare-dependent hospitals and low-volume hospitals permanent (the adjustments currently expire on March 31, 2025).

Fred Korematsu Congressional Gold Medal Act of 2025

Stopping Political Discrimination in Disaster Assistance Act

JOBS Act of 2025 Jumpstart Our Businesses by Supporting Students Act of 2025

Protect Infant Formula from Contamination ActThis bill imposes certain new requirements on infant formula manufacturers and the Food and Drug Administration (FDA) following the discovery of contaminated, adulterated, or misbranded infant formula. Specifically, the bill requires infant formula manufacturers to report to the FDA within one business day of learning that formula that was processed by the manufacturer but that is no longer within the manufacturer’s control may not provide required nutrients or may be otherwise adulterated or misbranded. Further, if any testing of finished infant formula reveals the presence of specified microorganisms (e.g., salmonella), the manufacturer must notify the FDA within one business day. (Under current law, manufacturers are only required to report contamination to the FDA if the affected formula has left the manufacturer’s control.) The manufacturer must also promptly provide the test results to the FDA and consult with the FDA on proper isolation and disposal of the affected product. The FDA must respond to such a notification and begin discussing proper investigative and corrective action with the manufacturer within one business day. Within 90 days of a report of adulterated, misbranded, or contaminated infant formula, the FDA must determine whether the manufacturer that reported the problem has performed, or is performing, appropriate investigative and corrective action. Finally, the FDA is required to periodically report on the infant formula supply chain and efforts to improve the safety and supply of infant formula, and must consult with other federal agencies and infant formula stakeholders on these issues.